SI2460509T1 - Sestavek za zdravljenje bradavic - Google Patents

Sestavek za zdravljenje bradavic Download PDF

Info

Publication number
SI2460509T1
SI2460509T1 SI201131416T SI201131416T SI2460509T1 SI 2460509 T1 SI2460509 T1 SI 2460509T1 SI 201131416 T SI201131416 T SI 201131416T SI 201131416 T SI201131416 T SI 201131416T SI 2460509 T1 SI2460509 T1 SI 2460509T1
Authority
SI
Slovenia
Prior art keywords
composition
use according
warts
formic acid
total amount
Prior art date
Application number
SI201131416T
Other languages
English (en)
Inventor
Flemming Licht
Original Assignee
Abbex Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbex Ab filed Critical Abbex Ab
Publication of SI2460509T1 publication Critical patent/SI2460509T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Claims (15)

  1. Sestavek za zdravljenje bradavic Patentni zahtevki
    1. Sestavek, ki obsega mravljično kislino in vsaj en C1-C4 alkil ester mlečne kisline, za uporabo v postopku topičnega zdravljenja bradavic, kjer je celokupna količina (m/m) navedenega estra v sestavku 10-70 %.
  2. 2. Sestavek za uporabo po zahtevku 1, kjer je navedeni vsaj en C1-C4 alkil ester etil laktat.
  3. 3. Sestavek za uporabo po katerem koli od predhodnih zahtevkov za aplikacijo neposredno na bradavice brez prebadanja bradavic ali strganja kože bradavic.
  4. 4. Sestavek za uporabo po katerem koli od predhodnih zahtevkov, kjer je celokupna količina (m/m) mravljične kisline v sestavku 1-90 %, bolj prednostno 3-85 %, prednostno 5-80 %, bolj prednostno 10-70 %, prednostno 15-65 %, bolj prednostno 20-60 %, bolj prednostno 25-50 %, prednostno 30-40 %, bolj prednostno 30-35 %.
  5. 5. Sestavek za uporabo po katerem koli od predhodnih zahtevkov, kjer je celokupna količina (m/m) mravljične kisline v sestavku 60-90 %, bolj prednostno 70-90 %, prednostno 80-85 %.
  6. 6. Sestavek za uporabo po zahtevku 5, kjer je navedeni sestavek za uporabo na trdih bradavicah.
  7. 7. Sestavek za uporabo po zahtevku 5 ali 6, kjer je navedeni sestavek za uporabo na dlani ali podplatu stopala.
  8. 8. Sestavek za uporabo po katerem koli od zahtevkov 1-4, kjer je celokupna količina (m/m) mravljične kisline v sestavku 10-60 %, bolj prednostno 15-50 %, prednostno 20-40 %, bolj prednostno 30-35 %.
  9. 9. Sestavek za uporabo po zahtevku 8 za uporabo na mehkih bradavicah.
  10. 10. Sestavek za uporabo po zahtevku 8 ali 9 za uporabo na druačnih mestih, kot je dlan ali podplat stopala.
  11. 11. Sestavek za uporabo po katerem koli od zahtevkov 8-10 za uporabo na nartu, hrbtišču roke, obrazu, vratu, zapestjih, kolenih ali genitalijah.
  12. 12. Sestavek za uporabo po katerem koli od predhodnih zahtevkov, ki obsega okoli 30 % mravljične kisline in okoli 70 % etil laktata.
  13. 13. Sestavek za uporabo po katerem koli od predhodnih zahtevkov, ki obsega okoli 85 % mravljične kisline in okoli 15 % etil laktata.
  14. 14. Pero za topično dajanje, ki obsega sestavek za uporabo po katerem koli od predhodnih zahtevkov.
  15. 15. Uporaba mravljične kisline in vsaj enega C1-C4 alkil estra mlečne kisline za izdelavo sestavka za topično zdravljenje bradavic, kjer je celokupna količina (m/m) navedenega estra v sestavku 10-70 %.
SI201131416T 2010-12-06 2011-12-02 Sestavek za zdravljenje bradavic SI2460509T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201070530 2010-12-06
EP11191792.8A EP2460509B1 (en) 2010-12-06 2011-12-02 Composition for the treatment of warts

Publications (1)

Publication Number Publication Date
SI2460509T1 true SI2460509T1 (sl) 2018-03-30

Family

ID=45093535

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201131416T SI2460509T1 (sl) 2010-12-06 2011-12-02 Sestavek za zdravljenje bradavic

Country Status (8)

Country Link
EP (1) EP2460509B1 (sl)
DK (1) DK2460509T3 (sl)
ES (1) ES2658287T3 (sl)
LT (1) LT2460509T (sl)
NO (1) NO2460509T3 (sl)
PL (1) PL2460509T3 (sl)
PT (1) PT2460509T (sl)
SI (1) SI2460509T1 (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104363885A (zh) * 2012-05-28 2015-02-18 阿贝克斯公司 用于疣的治疗的组合物
EP2692332B1 (en) * 2012-05-29 2019-08-21 Unigroup ApS Composition for the treatment of callus, corns and psoriasis
EP3804696A1 (en) 2019-10-07 2021-04-14 Unigroup ApS A multi-component wart destructing means

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5433950A (en) * 1990-05-07 1995-07-18 Schering-Plough Healthcare Products, Inc. Flexible collodion compositions
US5476664A (en) * 1994-04-15 1995-12-19 Leonard Bloom Treatment of warts using anthralins and occlusion
SE513436C2 (sv) * 1999-01-21 2000-09-11 Astrid Agholme Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus
MY162090A (en) * 2007-04-20 2017-05-31 Bioequal Ag Topically applicable fungicide agents for treating nails

Also Published As

Publication number Publication date
NO2460509T3 (sl) 2018-04-14
EP2460509A1 (en) 2012-06-06
ES2658287T3 (es) 2018-03-09
LT2460509T (lt) 2018-03-12
PL2460509T3 (pl) 2018-06-29
PT2460509T (pt) 2018-02-13
DK2460509T3 (en) 2018-02-12
EP2460509B1 (en) 2017-11-15

Similar Documents

Publication Publication Date Title
WO2011053792A3 (en) Methods and compositions for sustained delivery of drugs
WO2008154368A3 (en) Topical poloxamer formulations for enhancing microvascular flow: compositions and uses thereof
WO2011061330A3 (de) Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe
WO2010078285A3 (en) Pharmaceutical compositions and methods of treating neurological insults
PT2210588E (pt) Composição expansível, essencialmente isenta de ingredientes farmaceuticamente activos para o tratamento da pele humana
EA201291310A1 (ru) Композиция ингибитора jak для местного применения
WO2007059979A3 (en) Allergy treatment by epicutaneous allergen administration
MX2012000275A (es) Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
WO2012163928A3 (en) Topical wash composition for use in acne patients
WO2015038552A3 (en) Aspirin formulation for increased efficacy
NZ586302A (en) Pre-surgical treatment using brimonidine applied topically to reduce bleeding or bruising
WO2010039654A3 (en) Topical treatment of skin infection
SI2460509T1 (sl) Sestavek za zdravljenje bradavic
MX350224B (es) Formulaciones parasiticidas transdermicas.
CY1109733T1 (el) Χρησιμοποιηση πολυαιθυλενο γλυκολης για τη θεραπεια παθησεων ασθενειων και τραυματων, που εχουν σχεση με φλεγμονη
WO2009088673A3 (en) Pharmaceutical composition
WO2008099144A3 (en) Tgf-beta stimulant and further agent to reduce side effects
WO2007041388A3 (en) Prevention and treatment of hearing disorders
WO2012106058A3 (en) Animal treatments
WO2011011706A3 (en) Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents
WO2010135131A3 (en) Single-use, disposable strip for application of topical compositions
WO2009156675A3 (fr) Nouvelles compositions dépigmentantes sous forme d'une composition anhydre sans vaseline et sans élastomère comprenant un dérivé phénolique solubilisé et un rétinoïde
WO2009140059A3 (en) Narcotic emulsion formulations for treatment of surgical pain
WO2013083910A3 (fr) Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras en tant qu'analgesique, antalgique ou en tant que retardant sexuel
BRPI0602179A (pt) composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação